Skip to main content
Clinical Trials/CTRI/2017/12/010936
CTRI/2017/12/010936
Not yet recruiting
Phase 1

euronal activity, Cerebral Blood Flow & Hemodynamic Responses of Brain associated with Cognition following Yoga Practices in Diabetes Patients- a randomized controlled trial. - RCT

Ministry of AYUSH CCRY0 sites0 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Health Condition 1: null- Type 2 Diabetes
Sponsor
Ministry of AYUSH CCRY
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Ministry of AYUSH CCRY

Eligibility Criteria

Inclusion Criteria

  • 1\)Diagnosed with T2DM according to the 2010 criteria of the American Diabetes Association (ADA),
  • 2\)no T2DM\-related complications, including diabetic retinopathy, diabetic nephropathy, diabetic neuropathy and diabetic foot,
  • 3\)no history of hypoglycemia during the last two years,
  • 4\)Patients that did not practice Yoga in the last 3 months,
  • 5\)Not enrolled in any other alternative medicine programs,
  • 6\)Male and female subjects will be studied with cognitive task performance,
  • 7\)Willingness to participate in the trial

Exclusion Criteria

  • 1\) Mini\-Mental State examination (MMSE) scoreâ?? \<â??27; 2\)
  • 2\) BMIâ??\>\=â??30â??kg/m2
  • 3\) The presence of cognitive or neurological disorders, based on a medical history and routine clinical examination. In addition, the following two tests would be used:
  • (i) patients with pregnancy,
  • (ii) physical or mental disability to do Yoga,
  • (iii) history of drug, alcohol, or chemical abuse within 6 months prior to screening,
  • (iv) patients with any surgical organic disease, and
  • (v) inability to comply with study and follow\-up procedures.
  • 4\) The presence of a behavioral/psychological disorder: (i) the presence of behavioral/psychological impairments will be assessed using the Symptom Checklist\-90\-R (SCL\-90\-R). Subjects with significant deviations (exceeding one standard deviation) on these instruments will be excluded from the study.
  • (ii)Intake of medication, which is known to influence cognitive or autonomic functions.

Outcomes

Primary Outcomes

Not specified

Similar Trials